HIV immune plasma
Alternative Names: Immupath; PHTLatest Information Update: 24 Oct 2021
At a glance
- Originator Medicorp
- Developer HemaCare Corporation; Medicorp
- Class Antivirals
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Discontinued HIV infections
Most Recent Events
- 03 Jan 2020 HemaCare Corporation has been acquired by Charles River Laboratories
- 18 Apr 2005 Discontinued for HIV infections treatment in France (Parenteral)
- 18 Apr 2005 Discontinued for HIV infections treatment in United Kingdom (Parenteral)